{
    "2018-11-13": [
        [
            {
                "time": "2018-11-13",
                "original_text": "Health Care Sector Update for 11/13/2018: ABBV,VKTX,CRON,CRON.TO,VLRX",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update",
                        "ABBV",
                        "VKTX",
                        "CRON",
                        "VLRX"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-13",
                "original_text": "AbbVie's MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated Cirrhosis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "MAVYRET",
                        "Hepatitis",
                        "Cure",
                        "Patients",
                        "Cirrhosis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-13",
                "original_text": "Better Buy: AbbVie Inc. vs. GlaxoSmithKline PLC",
                "features": {
                    "keywords": [
                        "Better",
                        "Buy",
                        "AbbVie",
                        "GlaxoSmithKline"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-13",
                "original_text": "AbbVie to Present at the Evercore ISI Conference",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Evercore",
                        "ISI",
                        "Conference"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}